An Update on Animal Models of Osteogenesis Imperfecta

被引:2
|
作者
Lv, Fang [1 ]
Cai, Xiaoling [1 ]
Ji, Linong [1 ]
机构
[1] Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Xizhimen South St 11, Beijing 100044, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Osteogenesis imperfecta; Mouse models; Zebrafish models; Mechanism; SCLEROSTIN ANTIBODY TREATMENT; TRANSGENIC MOUSE MODEL; MARROW STROMAL CELLS; OIM MICE EXHIBIT; BONE FRAGILITY; PROLYL; 3-HYDROXYLATION; RETROVIRUS INSERTION; MURINE MODEL; COLLAGEN; MUTATIONS;
D O I
10.1007/s00223-022-00998-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteogenesis imperfecta (OI) is a heterogeneous disorder characterized by bone fragility, multiple fractures, bone deformity, and short stature. In recent years, the application of next generation sequencing has triggered the discovery of many new genetic causes for OI. Until now, more than 25 genetic causes of OI and closely related disorders have been identified. However, the mechanisms of many genes on skeletal fragility in OI are not entirely clear. Animal models of OI could help to understand the cellular, signaling, and metabolic mechanisms contributing to the disease, and how targeting these pathways can provide therapeutic targets. To date, a lot of animal models, mainly mice and zebrafish, have been described with defects in 19 OI-associated genes. In this review, we summarize the known genetic causes and animal models that recapitulate OI with a main focus on engineered mouse and zebrafish models. Additionally, we briefly discuss domestic animals with naturally occurring OI phenotypes. Knowledge of the specific molecular basis of OI will advance clinical diagnosis and potentially stimulate targeted therapeutic approaches.
引用
收藏
页码:345 / 366
页数:22
相关论文
共 50 条
  • [41] Osteoclast indices in osteogenesis imperfecta: systematic review and meta-analysis
    Aksornthong, Sirion
    Patel, Priyesh
    Komarova, Svetlana, V
    JBMR PLUS, 2024, 8 (11)
  • [42] Classification of osteogenesis imperfecta; [Klassifikation der Osteogenesis imperfecta]
    Fratzl-Zelman N.
    Misof B.M.
    Roschger P.
    Klaushofer K.
    Wiener Medizinische Wochenschrift, 2015, 165 (13-14) : 264 - 270
  • [43] Osteogenesis Imperfecta: Diagnosis and Treatment
    A. Biggin
    C. F. Munns
    Current Osteoporosis Reports, 2014, 12 : 279 - 288
  • [44] OSTEOGENESIS IMPERFECTA - WHICH ONE
    GUIBAUD, P
    PEDIATRIE, 1990, 45 (12): : 839 - 843
  • [45] Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta
    Moffatt, Pierre
    Boraschi-Diaz, Iris
    Marulanda, Juliana
    Bardai, Ghalib
    Rauch, Frank
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [46] Osteogenesis Imperfecta: Diagnosis and Treatment
    Biggin, A.
    Munns, C. F.
    CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (03) : 279 - 288
  • [47] Osteogenesis imperfecta
    Semler, O.
    Hoyer-Kuhn, H.
    Netzer, C.
    MEDIZINISCHE GENETIK, 2012, 24 (04) : 297 - 311
  • [48] Osteogenesis imperfecta
    Ibanez, Angelica
    Hodgson, Felipe
    REVISTA MEDICA CLINICA LAS CONDES, 2021, 32 (03): : 311 - 318
  • [49] Osteogenesis imperfecta
    Wirth, T.
    ORTHOPADE, 2012, 41 (09): : 773 - 782
  • [50] Treatment options for osteogenesis imperfecta
    Besio, Roberta
    Forlino, Antonella
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (02): : 165 - 181